Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
A Zaccardelli, ZS Wallace… - Current opinion in …, 2023 - journals.lww.com
Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …
Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases
Many patients with systemic autoimmune rheumatic diseases (SARDs) require
immunosuppression to reduce disease activity, but this also has important possible …
immunosuppression to reduce disease activity, but this also has important possible …
Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID …
Objective To examine the frequency of, and risk factors for, disease flare following COVID-19
vaccination in patients with systemic rheumatic disease (SRD). Methods An international …
vaccination in patients with systemic rheumatic disease (SRD). Methods An international …
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine …
Objective We investigated prolonged COVID-19 symptom duration, defined as lasting 28
days or longer, among people with systemic autoimmune rheumatic diseases (SARDs) …
days or longer, among people with systemic autoimmune rheumatic diseases (SARDs) …
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study
RK Topless, A Gaffo, LK Stamp… - The Lancet …, 2022 - thelancet.com
Background There is a paucity of data on outcomes for people with gout and COVID-19. We
aimed to assess whether gout is a risk factor for diagnosis of COVID-19 and COVID-19 …
aimed to assess whether gout is a risk factor for diagnosis of COVID-19 and COVID-19 …
COVID‐19 Vaccine Uptake, Hesitancy, and Flare in a Large Rheumatology Practice Network
EE Holladay, AS Mudano, F Xie… - Arthritis Care & …, 2024 - Wiley Online Library
Objective The goal of this study was to ascertain COVID‐19 vaccine uptake, reasons for
hesitancy, and self‐reported flare in a large rheumatology practice‐based network. Methods …
hesitancy, and self‐reported flare in a large rheumatology practice‐based network. Methods …
Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated …
Objectives To explore barriers and facilitators to COVID-19, influenza, and pneumococcal
vaccine uptake in immunosuppressed adults with immune-mediated inflammatory diseases …
vaccine uptake in immunosuppressed adults with immune-mediated inflammatory diseases …
COVID-19 vaccine hesitancy: The perils of peddling science by social media and the lay press
SA Thorakkattil, S Abdulsalim, MS Karattuthodi… - Vaccines, 2022 - mdpi.com
Introduction: Vaccines are the best tools to end the pandemic, and their public acceptance is
crucial in achieving herd immunity. Despite global efforts to increase access to vaccination …
crucial in achieving herd immunity. Despite global efforts to increase access to vaccination …
Rheumatic disease patient decision-making about COVID-19 vaccination: a qualitative analysis
Background Although patients with rheumatic and musculoskeletal diseases (RMDs) are at
increased risk for adverse outcomes of COVID-19 illness compared to healthy controls, they …
increased risk for adverse outcomes of COVID-19 illness compared to healthy controls, they …
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
P Sen, N Houshmand, S Moghadam Kia, M Joshi… - …, 2023 - academic.oup.com
Objective COVID-19 vaccines have a favorable safety profile in patients with autoimmune
rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however …
rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however …